Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Merck reports positive results from Phase III KEYNOTE-181 trial

Biopsy of a highly differentiated squamous cell carcinoma of the mouth Haematoxylin and eosin stain. Credit: KGH.



  • Merck

Go Top